(1 - 7 von 10
)
Novartis International AG: Novartis receives CHMP positive ...
www.finanznachrichten.de
"Today's news is a key milestone in our journey to reimagine asthma care by bringing innovative medicines and a digital companion to patients with uncontrolled asthma," said Linda Armstrong, MD ...
Novartis Phase III data on new inhaled dual combination QMF149 show...
www.myscience.org
Patients & Caregivers Healthcare Professionals Society & ESG Once-daily QMF149 met primary endpoint of lung function improvement and key secondary...
Novartis announces positive results from Phase III PALLADIUM study of...
www.myscience.org
Once-daily QMF149 demonstrated superior improvement in lung function versus mometasone furoate, meeting primary endpoint.
iBio Announces Appointment of Dr. Linda Armstrong to Boardwww.globenewswire.com › › iBio-Ann...
www.globenewswire.com
· Dr. Armstrong served in a variety of roles at Novartis since 2007, including the Head of Clinical Development & Medical Affairs, Cell and Gene ...
sortiert nach Relevanz / Datum